Envoy Medical Inc (COCH): Hedge Fund Ownership & Smart Money Signals (Q1 2026)

Q: Is it too late to buy Envoy Medical Inc (COCH) following the 2026 Q1 hedge fund 13F filings?

As of today, COCH has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), COCH gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Envoy Medical Inc (COCH)

32 + Investors. Track Smart Money conviction in COCH. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — COCH

Based on 32 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q

For 1 consecutive quarter, more hedge funds added COCH than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

32 hedge funds hold COCH right now — the highest count in 2.5 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +45% more funds vs a year ago

fund count last 6Q

+10 new funds entered over the past year (+45% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 67% buying

20 buying10 selling

Last quarter: 20 funds were net buyers (14 opened a brand new position + 6 added to an existing one). Only 10 were sellers (2 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+8 vs last Q)

new funds entering per quarter

Funds opening a new COCH position: 2 → 8 → 6 → 14. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 53% entered in last year

■ 16% conviction (2yr+) ■ 31% medium ■ 53% new

Only 5 funds (16%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

📈

Growing discovery — still being found

2 → 2 → 8 → 6 → 14 new funds/Q

New funds entering each quarter: 2 → 8 → 6 → 14. A growing number of institutions are discovering COCH each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.

🌱

Early stage — 62% of holders entered in last year

■ 16% veterans ■ 22% 1-2yr ■ 62% new

Of 32 current holders: 20 (62%) entered in the past year, only 5 (16%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

📋

Smaller funds dominant — 5% AUM from top-100

5% from top-100 AUM funds

11 of 32 holders rank in the top 100 by AUM, but together hold only 5% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

4.7

out of 10

Moderate Exit Risk

Exit risk score 4.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	32	26	23.08%
13F Shares	17M	1M	1230.49%
Total Value	$11M	$859K	1237.46%
New Positions	14	6	+8
Increased Positions	6	7	-1
Closed Positions	8	9	-1
Reduced Positions	2	4	-2
Total Calls	0	0	-
Total Puts	0	0	-
PUT/CALL Ratio	0.0	0.0	Bullish

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

23.08%

13F Shares

17M

1230.49%

Total Value

$11M

$859K

1237.46%

New Positions

Increased Positions

-1

Closed Positions

-1

Reduced Positions

-2

Total Calls

Total Puts

PUT/CALL Ratio

0.0

Bullish

Institutional Holders (2026 Q1)

32 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in COCH. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 COCH holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Bleichroeder LP	0.72%	6,250,000	$4.2M
2	Nantahala Capital Management, LLC	0.19%	7,650,000	$5.1M
3	DSG Capital Advisors, LLC	0.07%	625,000	$416K
4	Arcus Capital Partners, LLC	0.04%	187,573	$124K
5	Lantern Wealth Advisors, LLC	0.01%	30,000	$20K
6	Afg Fiduciary Services Limited Partnership	0.00%	12,000	$8K
7	Ballew Advisors, Inc	0.00%	10,121	$7K
8	Two Sigma Securities, LLC	0.00%	23,121	$15K
9	Meteora Capital, LLC	0.00%	28,051	$19K
10	BlueStem Wealth Partners, LLC	0.00%	10,454	$7K
11	American Capital Advisory, LLC	0.00%	2,000	$1K
12	Focus Partners Wealth	0.00%	212,655	$141K
13	Tower Research Capital LLC (TRC)	0.00%	5,665	$4K
14	CIBC Bancorp USA Inc.	0.00%	77,887	$52K
15	Vanguard Fiduciary Trust Co	0.00%	294,721	$196K
16	Cwm, LLC	0.00%	16,500	$11K
17	Farther Finance Advisors, LLC	0.00%	3,000	$2K
18	Vanguard Capital Management LLC	0.00%	881,672	$586K
19	UBS Group AG	0.00%	70,459	$47K
20	LPL Financial LLC	0.00%	28,401	$19K
21	Rockefeller Capital Management L.P.	0.00%	2,800	$2K
22	Morgan Stanley	0.00%	73,900	$49K
23	Goldman Sachs Group Inc	0.00%	36,462	$24K
24	Susquehanna International Group, LLP	0.00%	35,297	$23K
25	BlackRock, Inc.	0.00%	47,514	$32K

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Envoy Medical Inc (COCH)

What does the Smart Money Trend signal show for COCH?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added COCH than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for COCH?

More buyers than sellers — 67% buying: Last quarter: 20 funds were net buyers (14 opened a brand new position + 6 added to an existing one). Only 10 were sellers (2 trimmed + 8 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for COCH holders?

Smaller funds dominant — 5% AUM from top-100: 11 of 32 holders rank in the top 100 by AUM, but together hold only 5% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held COCH?

Mostly new holders — 53% entered in last year: Only 5 funds (16%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Is it too late to buy Envoy Medical Inc (COCH) following the 2026 Q1 hedge fund 13F filings?

As of today, COCH has moved nan% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of nan%. Since the quarter end (March 31, 2026), COCH has gained nan% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Envoy Medical Inc (COCH)

Smart Money Signals — COCH

Buying streak — 1 quarter in a row

At the ownership peak (100% of max)

Fast accumulation — +45% more funds vs a year ago

More buyers than sellers — 67% buying

More new buyers each quarter (+8 vs last Q)

Mostly new holders — 53% entered in last year

Growing discovery — still being found

Early stage — 62% of holders entered in last year

Smaller funds dominant — 5% AUM from top-100

Institutional Sentiment Summary — COCH

Hedge Fund Ownership: COCH

Market Analysis: COCH

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: COCH

Is It Too Late to Buy Envoy Medical Inc (COCH) Based on Hedge Fund 13F Filings?

Hedge Fund Positioning: COCH

Statistics: COCH

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q1)

Frequently Asked Questions — Envoy Medical Inc (COCH)

Welcome to 13Foresight!